They showed that M-MDSCs were significantly elevated in CLL patients compared with MBL and control cases and that they were associated with adverse prognostic factors, such as advanced disease stage, CD38 and ZAP-70 expression, as well as IGHV unmutated CLL cases. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.